Articles tagged with: OGXI

OncoGenex Pharmaceuticals Inc has recently announced that the Food and Drug Administration panel has approved their additional fast-track designation to their new prostrate cancer drug, OGX-011, in combination with the first-line chemotherapy. The news about …

So we have noticed the FDA has been missing more and more dates so far this year. One reasons I saw for the FDA missing a date was due to “staffing issues”. Is the FDA …